Perrigo (PRGO) Profit After Tax Growth (1y) (2013 - 2026)
Perrigo (PRGO) Profit After Tax Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 67.73% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -388.33% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1,682.88% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -14.93% |
| 10 | Perrigo | 1.42 Bn | 1.06 Bn | 325.50 Mn | -5,990.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -5,990.63% |
| Dec 31, 2025 | -4,204.49% |
| Sep 27, 2025 | 160.48% |
| Jun 28, 2025 | 234.13% |
| Mar 29, 2025 | 86.78% |
| Dec 31, 2024 | -20.58% |
| Sep 28, 2024 | -236.36% |
| Jun 29, 2024 | -513.74% |
| Mar 30, 2024 | -333.82% |
| Dec 31, 2023 | -118.11% |
| Sep 30, 2023 | 129.56% |
| Jul 1, 2023 | 116.19% |
| Apr 1, 2023 | 200.98% |
| Dec 31, 2022 | -139.56% |
| Oct 1, 2022 | 3.34% |
| Jul 2, 2022 | -180.42% |
| Apr 2, 2022 | 82.67% |
| Dec 31, 2021 | 118.34% |
| Oct 2, 2021 | 65.14% |
| Jul 3, 2021 | -168.04% |